Study Conduct

START expands with phase I center in Shanghai

Thursday, September 22, 2011 10:45 AM

South Texas Accelerated Research Therapeutics (START), a US-based group that claims to run the world’s largest co-ordinated network of phase I clinical trials in oncology, has opened a phase I research facility in China at Fudan University Shanghai Cancer Centre, the city’s largest cancer hospital, according to PharmaTimes.

More... »

BBK Worldwide expands with in-house distribution center

Tuesday, September 20, 2011 11:20 AM

In a joint effort with Ricoh Americas, BBK Worldwide has expanded its production facility to include full-service, in-house distribution services, called Distribution Central. "The motivation to provide these services through our sister creative company, Agency 320, is clear: reduce the time-to-market for critical materials that support the recruitment and retention of patients around the world," said Joan F. Bachenheimer, founding principal and CEO, BBK Worldwide.

More... »

UK firms go to Russia to conduct cheaper clinical trials

Tuesday, September 20, 2011 11:13 AM

Britain's fastest-growing bio-technology firms are flocking to Russia to run clinical trials more cheaply and quickly than they can in the West, according to This is MONEY.

More... »

Re-accredited Russian investigative sites jump to almost 600 under new regulations’ Sept. 1 deadline

Monday, September 19, 2011 08:00 AM

The number of investigative sites that have been re-accredited by the Russian Ministry of Health (MoH)—a requirement inherent in the country’s new regulations—is now up to almost 600, according to the Association of Clinical Trials Organizations (ACTO), a trade group for those working in research in Russia.

More... »

Study: 60% of protocols amended during clinical trials

Wednesday, September 14, 2011 10:41 AM

Nearly 60% of all protocols used in clinical trials for new drugs are amended during the study, but one-third of those changes could have been avoided, according to a new study, reported by PharmaTimes.

More... »

Canadian government launches massive overhaul of clinical research process to create infrastructure

Monday, September 12, 2011 08:00 AM

The Canadian Institutes of Health Research (CIHR)—the federal government’s health research investment agency—is undertaking a massive overhaul of how clinical research is conducted, attempting to align large sites and other parties in all provinces to create an integrated research infrastructure.

More... »

Aridhia partners with Glencoe Software

Tuesday, September 6, 2011 02:35 PM

Aridhia Informatics, a healthcare informatics company based in Glasgow, Scotland, has formed a strategic partnership with US company Glencoe Software to create support tools for the development of personalized medicine using real-world clinical, genetic and research data, according to PharmaTimes.

More... »

Mayo Clinic sees potential of social media in patient recruitment

Thursday, September 1, 2011 12:32 PM

Social media and online networks could be of particular value in initiating, and recruiting patients for, studies of sometimes neglected rare medical conditions, US-based non-profit Mayo Clinic has found, according to PharmaTimes.

More... »

Study: Cancer patients rarely participate in trials

Friday, August 26, 2011 01:14 PM

Very few patients who've had cancer surgery end up participating in clinical trials to test new treatments, researchers have found, according to Reuters.

More... »

Physicians wary of using biosimilars

Wednesday, August 24, 2011 01:58 PM

Decision Resources finds that the majority of U.S. and European physicians are wary of using a biosimilar for an indication for which supporting clinical data are lacking. According to new analysis, physician attitudes about indication extrapolation-where a biosimilar needs only to show similarity in a phase III study for one indication, and it will be granted approval for other indications for which the branded product is used-vary by country. French physicians are the most conservative when asked about indication extrapolation when compared to German and U.S. physicians.

More... »